Related references
Note: Only part of the references are listed.New strategies to treat AML: novel insights into AML survival pathways and combination therapies
Ramya Nair et al.
LEUKEMIA (2021)
The nuclear phosphoinositide response to stress
Mo Chen et al.
CELL CYCLE (2020)
A User's Guide to Novel Therapies for Acute Myeloid Leukemia
Shyam A. Patel et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
PI(3,4)P2 Signaling in Cancer and Metabolism
Luca Gozzelino et al.
FRONTIERS IN ONCOLOGY (2020)
First-in-Human Phase I Study of ladademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia
Olga Salamero et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Signaling through non-membrane nuclear phosphoinositide binding proteins in human health and disease
Jamal M. Bryant et al.
JOURNAL OF LIPID RESEARCH (2019)
Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells
Francesca Chiarini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes
Matilde Y. Follo et al.
LEUKEMIA (2019)
ORP4L Extracts and Presents PIP2 from Plasma Membrane for PLCβ3 Catalysis: Targeting It Eradicates Leukemia Stem Cells
Wenbin Zhong et al.
CELL REPORTS (2019)
Class II PI3K Functions in Cell Biology and Disease
Federico Gulluni et al.
TRENDS IN CELL BIOLOGY (2019)
Nuclear Phosphoinositides: Their Regulation and Roles in Nuclear Functions
R. Fiume et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
AGILE: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Ivosidenib in Combination with Azacitidine in Adult Patients with Previously Untreated Acute Myeloid Leukemia with an IDH1 Mutation
Pau Montesinos Fernandez et al.
BLOOD (2019)
Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects
Valentina Gambacorta et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-trans retinoic acid in acute myeloid leukemia across subtypes
Kimberly N. Smitheman et al.
HAEMATOLOGICA (2019)
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders[S]
Stefano Ratti et al.
JOURNAL OF LIPID RESEARCH (2019)
Phosphoinositide conversion in endocytosis and the endolysosomal system
Alexander Wallroth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo
Yongwei Su et al.
BIOCHEMICAL PHARMACOLOGY (2018)
PIP2 epigenetically represses rRNA genes transcription interacting with PHF8
Livia Ulicna et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2018)
Dueling for dual inhibition: Means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML
Lauren Herschbein et al.
BLOOD REVIEWS (2018)
ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia
Tamara Maes et al.
CANCER CELL (2018)
Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells
Mohamed Rahmani et al.
CANCER RESEARCH (2018)
Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs)
Alessandro Poli et al.
FASEB JOURNAL (2018)
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
C. D. DiNardo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia
Daniela Magliulo et al.
FRONTIERS IN ONCOLOGY (2018)
Precision medicine in the treatment stratification of AML patients: challenges and progress
Ines Lohse et al.
Oncotarget (2018)
The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia
Iman Abou Dalle et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2018)
ORP5 and ORP8 bind phosphatidylinositol-4,5-biphosphate (PtdIns(4,5)P2) and regulate its level at the plasma membrane
Rajesh Ghai et al.
NATURE COMMUNICATIONS (2017)
Peptide microarray profiling identifies phospholipase C gamma 1 (PLC-γ1) as a potential target for t(8;21) AML
Hasan Mahmud et al.
Oncotarget (2017)
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Eytan M. Stein et al.
BLOOD (2017)
Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes
Sara Mongiorgi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Phosphoinositides in the nucleus and myogenic differentiation: how a nuclear turtle with a PHD builds muscle
Nullin Divecha
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes
John P. McGrath et al.
CANCER RESEARCH (2016)
Selective Activation of Nuclear PI-PLCbeta1 During Normal and Therapy-Related Differentiation
Sara Mongiorgi et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination
Jason S. L. Yu et al.
DEVELOPMENT (2016)
Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management
Khurum H. Khan et al.
ONCOLOGIST (2016)
ORP4L is essential for T-cell acute lymphoblastic leukemia cell survival
Wenbin Zhong et al.
NATURE COMMUNICATIONS (2016)
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
Marina Konopleva et al.
CANCER DISCOVERY (2016)
PI3K signalling in inflammation
P. T. Hawkins et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes
Lucio Cocco et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
The Basal Transcription Complex Component TAF3 Transduces Changes in Nuclear Phosphoinositides into Transcriptional Output
Yvette Stijf-Bultsma et al.
MOLECULAR CELL (2015)
MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
G. S. Choudhary et al.
CELL DEATH & DISEASE (2015)
Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia
N. Sandhoefer et al.
LEUKEMIA (2015)
A targeted knockdown screen of genes coding for phosphoinositide modulators identifies PIP4K2A as required for acute myeloid leukemia cell proliferation and survival
J. G. Jude et al.
ONCOGENE (2015)
Accessibility of Different Histone H3-Binding Domains of UHRF1 Is Allosterically Regulated by Phosphatidylinositol 5-Phosphate
Kathy A. Gelato et al.
MOLECULAR CELL (2014)
Signaling by the Phosphoinositide 3-Kinase Family in Immune Cells
Klaus Okkenhaug
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Phosphatidylinositol-4-phosphate: The Golgi and beyond
Maria A. De Matteis et al.
BIOESSAYS (2013)
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
Gabriele Migliorini et al.
BLOOD (2013)
Low PIP4K2B Expression in Human Breast Tumors Correlates with Reduced Patient Survival: A Role for PIP4K2B in the Regulation of E-Cadherin Expression
Willem-Jan Keune et al.
CANCER RESEARCH (2013)
Nuclear phosphoinositides and their impact on nuclear functions
Zahid H. Shah et al.
FEBS JOURNAL (2013)
Novel Susceptibility Variants at 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethnically Diverse Populations
Heng Xu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier
Akira Watanabe et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2013)
Nuclear phosphatidylinositol-5-phosphate regulates ING2 stability at discrete chromatin targets in response to DNA damage
Dennis J. Bua et al.
SCIENTIFIC REPORTS (2013)
The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia
Roel Polak et al.
BLOOD (2012)
The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
William J. Harris et al.
CANCER CELL (2012)
Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemia
Joanna Szczepanek et al.
JOURNAL OF APPLIED GENETICS (2012)
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients
M. Y. Follo et al.
LEUKEMIA (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
Tino Schenk et al.
NATURE MEDICINE (2012)
Identification of Nuclear Phosphatidylinositol 4,5-Bisphosphate-Interacting Proteins by Neomycin Extraction
Aurelia E. Lewis et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains
Benchun Miao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Tumor Suppression by Phospholipase C-β3 via SHP-1-Mediated Dephosphorylation of Stat5
Wenbin Xiao et al.
CANCER CELL (2009)
PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions
Iman van den Bout et al.
JOURNAL OF CELL SCIENCE (2009)
Phosphoinositide-Phospholipase C β1 Mono-Allelic Deletion Is Associated With Myelodysplastic Syndromes Evolution Into Acute Myeloid Leukemia
Matilde Y. Follo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia
N. Gallay et al.
LEUKEMIA (2009)
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS
Matilde Y. Follo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
PI-PLC beta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes
M. Y. Follo et al.
LEUKEMIA (2008)
Signalling through class I PI3Ks in mammalian cells
P. T. Hawkins et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Phosphoinositides in cell regulation and membrane dynamics
Gilbert Di Paolo et al.
NATURE (2006)
Nuclear PtdIns5P as a transducer of stress signaling: An in vivo role for PIP4Kbeta
David R. Jones et al.
MOLECULAR CELL (2006)
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia
A. M. Martelli et al.
LEUKEMIA (2006)
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription
E Metzger et al.
NATURE (2005)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor
O Gozani et al.
CELL (2003)
Up-regulation of nuclear PLCβ1 in myogenic differentiation
I Faenza et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)
G Del Poeta et al.
BLOOD (2003)
Phosphatidylinositol-dependent actin filament binding by the SWI/SNF-like BAF chromatin remodeling complex
OJ Rando et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
